# Department of Defense-Navy; US Naval Hospital Yokosuka – FDA Inspection, Jun 7, 2016

Source: https://www.keypedia.com/records/fda_inspections/department-of-defense-navy-us-naval-hospital-yokosuka/bcf63aad-3f9d-453a-af40-7a65b940b17e
Source feed: FDA_Inspections

> FDA inspection 976044 of Department of Defense-Navy; US Naval Hospital Yokosuka, June 07, 2016. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 606. 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 976044
- Company Name: Department of Defense-Navy; US Naval Hospital Yokosuka
- Inspection Date: 2016-06-07
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 1

## Related Documents

- FDA Inspection 1340796 - 2026-09-18
- FDA Inspection 1243237 - 2024-06-14
- FDA Inspection 1177989 - 2022-07-19
- FDA Inspection 1054442 - 2018-05-01
- [FDA Inspection 876329 - 2014-04-18](https://www.keypedia.com/records/fda_inspections/department-of-defense-navy-us-naval-hospital-yokosuka/2427f4b1-b0d0-4107-a9d8-032df3f6482a)

Company: https://www.keypedia.com/companies/department-of-defense-navy-us-naval-hospital-yokosuka/a7b39be2-6622-4731-828f-945d2dde8594

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d